A federal jury in Boston convicts Insys Therapeuticss founder and four former executives on charges they bribed health professionals to prescribe Subs...
Five stakeholders give FDA technical comments on a draft guidance on food effects on drugs.
Researchers say U.S. trade agreement containing protections sought by drug companies dont always provide benefits to Americans promised as part of the...
FDA posts a summary of changes to 17 REMS made in March and April.
Reuters reports the Justice Department is intervening in two whistleblower suits alleging that Questcor Pharmaceuticals illegally promoted its Acthar ...
FDA clears a Lensar 510(k) for the Lensar Laser System with Streamline IV to expand the platforms capabilities to include the creation of micro radial...
Sagent Pharmaceuticals recalls one lot of ketorolac tromethamine injection due to lack of sterility assurance.
FDA solicits feedback on its priority list of patient preference-sensitive areas intended to help the medical device industry and researchers.